KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Short-term Investments: 2010-2025

Historic Short-term Investments for Emergent BioSolutions (EBS) over the last 7 years, with Sep 2025 value amounting to $3.7 million.

  • Emergent BioSolutions' Short-term Investments fell 43.08% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 43.08%. This contributed to the annual value of $6.1 million for FY2024, which is N/A change from last year.
  • Emergent BioSolutions' Short-term Investments amounted to $3.7 million in Q3 2025, which was down 0.00% from $3.7 million recorded in Q2 2025.
  • Emergent BioSolutions' Short-term Investments' 5-year high stood at $6.5 million during Q3 2024, with a 5-year trough of $100,000 in Q3 2022.
  • In the last 2 years, Emergent BioSolutions' Short-term Investments had a median value of $3.7 million in 2025 and averaged $3.6 million.
  • Per our database at Business Quant, Emergent BioSolutions' Short-term Investments plummeted by 50.00% in 2022 and then skyrocketed by 640.00% in 2025.
  • Quarterly analysis of 4 years shows Emergent BioSolutions' Short-term Investments stood at $200,000 in 2021, then crashed by 50.00% to $100,000 in 2022, then reached $6.1 million in 2024, then tumbled by 43.08% to $3.7 million in 2025.
  • Its Short-term Investments stands at $3.7 million for Q3 2025, versus $3.7 million for Q2 2025 and $3.7 million for Q1 2025.